On Monday, Merck & Co Inc (NYSE: MRK) opened lower -0.19% from the last session, before settling in for the closing price of $78.00. Price fluctuations for MRK have ranged from $75.93 to $134.63 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 7.14% over the past five years. Company’s average yearly earnings per share was noted 17.01% at the time writing. With a float of $2.51 billion, this company’s outstanding shares have now reached $2.53 billion.
Let’s look at the performance matrix of the company that is accounted for 75000 employees. In terms of profitability, gross margin is 80.85%, operating margin of 35.36%, and the pretax margin is 31.07%.
Merck & Co Inc (MRK) Insider Updates
A key investor’s attitude towards the stock of the Drug Manufacturers – General industry is another important factor to consider. The insider ownership of Merck & Co Inc is 0.09%, while institutional ownership is 80.41%. The most recent insider transaction that took place on Feb 19 ’25, was worth 714,745. In this transaction President, U.S. Market of this company sold 8,500 shares at a rate of $84.09, taking the stock ownership to the 30,705 shares. Before that another transaction happened on Feb 19 ’25, when Company’s Officer proposed sale 8,500 for $84.09, making the entire transaction worth $714,745.
Merck & Co Inc (MRK) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.11 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 17.01% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.34% during the next five years compared to 12.04% growth over the previous five years of trading.
Merck & Co Inc (NYSE: MRK) Trading Performance Indicators
Check out the current performance indicators for Merck & Co Inc (MRK). In the past quarter, the stock posted a quick ratio of 1.15. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.06. Likewise, its price to free cash flow for the trailing twelve months is 10.83.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 6.73, a number that is poised to hit 2.14 in the next quarter and is forecasted to reach 9.83 in one year’s time.
Technical Analysis of Merck & Co Inc (MRK)
Merck & Co Inc (NYSE: MRK) saw its 5-day average volume 16.16 million, a negative change from its year-to-date volume of 16.35 million. As of the previous 9 days, the stock’s Stochastic %D was 27.52%. Additionally, its Average True Range was 2.86.
During the past 100 days, Merck & Co Inc’s (MRK) raw stochastic average was set at 6.59%, which indicates a significant decrease from 13.89% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 41.09% in the past 14 days, which was higher than the 29.92% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $87.82, while its 200-day Moving Average is $103.39. Nevertheless, the first resistance level for the watch stands at $78.36 in the near term. At $78.88, the stock is likely to face the second major resistance level. The third major resistance level sits at $79.56. If the price goes on to break the first support level at $77.16, it is likely to go to the next support level at $76.48. Assuming the price breaks the second support level, the third support level stands at $75.96.
Merck & Co Inc (NYSE: MRK) Key Stats
There are currently 2,521,759K shares outstanding in the company with a market cap of 195.90 billion. Presently, the company’s annual sales total 64,168 M according to its annual income of 17,117 M. Last quarter, the company’s sales amounted to 15,624 M and its income totaled 3,743 M.
